• Home
  • About
  • HEAG Foundation
  • Photographs
  • Media
  • Blog
  • Contact
  • Privacy Policy

How Hepatitis Became A Hidden Epidemic In Africa

3/10/2017

3 Comments

 
Image 20170309 21034 1nv7qgj
Health centre in Sainte Dominique, Dakar, Senegal. Jean-Jacques Lemasson/IRD, CC BY-SA
Fanny Chabrol, Institut national de la santé et de la recherche médicale (Inserm)

The five strains of viral hepatitis (A, B, C, D and E) affect 400 million people around the world. Hepatitis B and C are the most deadly; these infections are blood borne, transmitted mainly through unsafe medical practices or injection drug use.

International awareness has grown following activist mobilisation denouncing the exorbitant prices of new drugs that can cure hepatitis C such as Solvadi, priced at US$1,000 a pill.

Viral hepatitis is a global epidemic with distinct regional patterns. In Europe, hepatitis C is mostly associated with injecting drugs but on the African continent, it is a generalised epidemic and a major public health issue.

In both 2010 and 2014, the World Health Organisation (WHO) called for action on the diseases and has since produced guidelines for testing for hepatitis B and C.

The case of viral hepatitis sheds light on the key challenges faced by health systems in Africa in relation to the prevention of infection, barriers to accessing care and treatments and social and economic equity.

A deadly epidemic

It is estimated that 100 million people are affected by chronic hepatitis B in Africa, most of whom don’t know they have the infection; 19 million adults have hepatitis C.

Despite a lack of accurate epidemiological data at national levels, various estimations put hepatitis B prevalence at around 8-10% of the population in many countries. It is a generalised epidemic, not confined to specific segments of the population or high-risk groups.

This epidemic is even more worrying when we consider how hard it is to get treated – only 1% of chronic carriers can access treatment. When patients test positive for hepatitis they must undergo a series of biological and molecular tests that are, at the moment, unacceptably expensive in Africa.

It costs between €200 and €400 to have a complete pre-therapeutic assessment for hepatitis B or C in Cameroon and around €210 for an assessment for hepatitis B in Burkina-Faso.

Pharmaceuticals, Am Timan market, Chad. Abdoulaye Barry/MSF

After these tests, very few patients make it to the antiretroviral treatments. which are available for HIV patients but not for those affected by hepatitis B. In the case of hepatitis C, a single injection of pegylated interferon can cost as much as €230 in Côte d’Ivoire or Cameroon, and patients need 46 injections minimum.

If a hepatitis patient cannot access regular treatment, they end up hospitalised, affecting entire families both emotionally and financially. The people who die young of the diseases represent the workforce in many countries. As in the early years of AIDS, the shape of Africa’s future is affected by these infections.

A history of neglect

And just as the AIDS epidemic embodied colonial violence and weak health systems, so does viral hepatitis.

In Cameroon, the hepatitis C virus was transmitted through colonial medical campaigns in the late 1950s to 1960s. In Ebolowa, it is associated with intravenous treatment of malaria that today’s older people received when they were young; hepatitis C therefore affects more than 50% of people older than 50 in certain regions.

Group shot of seven Europeans at the opening of the first Mengo Hospital, Uganda, 1897. Wellcome

Transmission of hepatitis C might not be acute today, but certain medical procedures do carry the risk of infection. In Cameroon, those who undergo repeated blood transfusions are at greater risk of contracting HCV, just as health workers, exposed in the workplace.

Viral hepatitis also sheds light on global healthcare priorities. The hepatitis B vaccines arrived late to the African continent: though the extent of hepatitis B and liver cancer were known in the late 1970s in Senegal and stimulated the development of a vaccine, once manufactured this vaccine was not made accessible in Africa until mid-1990s. Even today, populations are not fully covered by vaccination.

In the 1980s the HIV epidemic obscured the extent of hepatitis. Today, the free antiretroviral drugs provided through the support of Global Fund against HIV, TB and malaria are perceived as unfair by many of those affected by hepatitis.

People’s science

In the fight against hepatitis, many lessons can be drawn from HIV, as well as from the recent Ebola outbreak*.

Massive international interventions cannot just target access to drugs and biomedical interventions. Chances of surviving Ebola were considerably increased when patients could access basic measures, including intensive care and rehydration.

And instead of trying to change people’s behaviour, history shows it is wiser to understand the social, economic and political context of epidemics and to trust local knowledge and experience. In his recent book on Ebola, anthropologist Paul Richards asserts that the epidemic ended not just because of international support, but also thanks to community work, even despite the lack of effective treatment.

Communities responded, and they produced their own science of the disease. They mobilised techniques to protect themselves, for instance by using plastic bags or other materials while attending to their sick loved ones.

Freetown Ebola burial team carefully lowers the corpse of a small child into its grave. Simon Davis/Dfid, CC BY-SA

Today, in places like Cameroon, many physicians, patients and families have similarly developed ways to cope with hepatitis, jaundice or liver pathologies. Their insight and experience should be at the centre of future policies.

Many professionals deplore the lack of universal protection from hepatitis transmission and the risk of infection in hospitals is high. Health workers are not immunised correctly, and they lack critical equipment such as gloves and sterilising material.

Another efficient way to prevent transmission is to vaccinate for hepatitis at birth instead of starting at six weeks.

There is also an urgent need to address pain management and palliative care as the complications of hepatitis (liver cancer and cirrhosis) can be very debilitating and inhumane experiences, often leading to death.

Urgent action

Across the African continent, hepatitis does not today receive the same kind of attention from NGOs and civil society as HIV did in the 2000s.

But other forms of mobilisation are emerging among clinicians, as national professional associations combine scientific and medical work and advocate to their respective governments for sustained pan-African collaboration.

Democratic Republic of Congo. Young people are vaccinated to prevent measles, hepatitis and whooping cough. MSF

Clinicians in Africa and in Europe are also joining forces through scientific and medical cooperation and are calling for action to fight these unacceptable global inequalities. Their insights should be combined with strong social support for patients and their families.

The viral hepatitis response also requires urgent infrastructure interventions to ensure access to clean water, hospital hygiene and blood safety.

The WHO Regional Committee for Africa promotes a public health approach that includes vaccination at birth, integration of testing services and linkage to care.

If making drugs available is a priority, it is also imperative to avoid catastrophic health expenses and include diagnostic tests, treatments and follow-up tests in national projects for universal health coverage.

Fanny Chabrol, Postdoctoral fellow in Global health, Institut national de la santé et de la recherche médicale (Inserm)

This article was originally published on The Conversation. Read the original article.

3 Comments
Joyce
11/3/2017 16:44:21

i was cured of hepatitis b by med lab, anyone with the same virus or any other diseases should contact med lab via: medlab36@gmail.com

Reply
Joyce
11/3/2017 16:45:45

Am here to appreciate MED LAB for curing my hepatitis b virus. since 5 years now I have been living with this virus and it has been giving me challenges, I was so perplexed cause i have been taking several drugs to be cured but all of my effort was in vain,one morning i was browsing through the internet then i saw several testimonies about MED LAB curing people from Herpes virus, Hepatitis b and others, and immediately i contacted MED LAB email: medlab36@gmail.com i told them about my troubles and they told me that i will be cured, gave me some instructions and which i rightly followed. so they sent medicine for me and i used it just 8 days and everything was like a dream to me and my Hepatitis b virus was totally gone, why don't you contact them today and be free from your diseases because life is so sweet and opportunities are await us. contact via email; medlab36@gmail.com

Reply
Lisa Jay
8/14/2020 08:59:43

It was the first time my granddaughter came to me and confided about her battle with oral and genital herpes and her self destructive thoughts.
A gaping vacuum of fear and love opened inside me. I knew what it felt like for her to be in such a situation. But after hearing how someone I loved so dearly struggled I have no option but to promise her help. I wanted to help in all possible ways. I sought counsels from an old and experienced nurse whom I've known to deal on natural herbs because I believed in nature. After hearing from me she smiled and before I could say another word she replied me there's cure but natural herbs. I don't care as long as my child is cured! I shouted. She told me about a doctor in Africa who has cured people of herpes. She gave me his email drutuherbalcure@gmail.com ,I contacted him immediately and then ordered medicine for my child which he sent through the UPS courier to me. My daughter started medication and the next day her mouth sores were physically healing and she told me it's working and within four weeks she testified to me that she was cured! I've always believed that nature has cure for any diseases and I'm happy to tell everyone my child is cured.
Six months later we went for another test to be sure and here is the result,
Six months after medications;
Her hsv1&2 test results;
Igm - 1.49
IgG - 0.36
She don't have any symptoms again and has moved on happily and is now in a serious relationship with her fiancee

Reply



Leave a Reply.

    Tweets by @ScienceInsider

    Archives

    December 2017
    October 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    July 2016
    June 2016
    May 2016

    Categories

    All

    RSS Feed

Home
About
Contact
​Privacy Policy

HEAG Medical Community Ghana ("HMCG") Project

HMCG operates a multi-disciplinary physicians office, which will include private care physician services, as well as physical therapy services, a dialysis center, and a rehabilitative center, among other services.  It will have approximately 120 to 150 beds.

HEAG Medical Center Ghana (“HMCG”) is established as a private, for-profit service provider, Phase  I  new 41,000 sustainable medical care/treatment square foot facilities. It will build a strong market presence and brand recognition by offering the highest quality, world-class services at a competitive price. HMCG will meet the broad healthcare needs of a growing and demanding higher income demographic in the Greater Accra Region, and also providing medical health humanitarian outreach services for the rest of Ghana, and beyond.


HMCG will provide partnering opportunities with specialists, both national and international, in every medical and surgical field, will network with pharmaceutical FDA Drugs, Medical supplies providing management and distribution.  The HEAG Medical Management Team will provide the ability to set up private practices within the facility. These medical professionals will work effectively with each other to ensure a team-based approach to patient care which will be a key to HMCG’s success.
Partnered & Sponsored by DAJK GROUP
  • Home
  • About
  • HEAG Foundation
  • Photographs
  • Media
  • Blog
  • Contact
  • Privacy Policy